vs

Side-by-side financial comparison of ASTRONICS CORP (ATRO) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.

ASTRONICS CORP is the larger business by last-quarter revenue ($240.1M vs $164.7M, roughly 1.5× PTC THERAPEUTICS, INC.). On growth, ASTRONICS CORP posted the faster year-over-year revenue change (15.1% vs -22.7%). ASTRONICS CORP produced more free cash flow last quarter ($15.8M vs $-36.6M). Over the past eight quarters, ASTRONICS CORP's revenue compounded faster (13.9% CAGR vs -11.5%).

Astronics Corporation is an American aerospace electronics corporation founded in 1968, headquartered in East Aurora, New York. It is traded on NASDAQ as Nasdaq: ATRO. It is known for lighting and electronics integrations on military, commercial, and business aircraft and semiconductor test systems.

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.

ATRO vs PTCT — Head-to-Head

Bigger by revenue
ATRO
ATRO
1.5× larger
ATRO
$240.1M
$164.7M
PTCT
Growing faster (revenue YoY)
ATRO
ATRO
+37.9% gap
ATRO
15.1%
-22.7%
PTCT
More free cash flow
ATRO
ATRO
$52.5M more FCF
ATRO
$15.8M
$-36.6M
PTCT
Faster 2-yr revenue CAGR
ATRO
ATRO
Annualised
ATRO
13.9%
-11.5%
PTCT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ATRO
ATRO
PTCT
PTCT
Revenue
$240.1M
$164.7M
Net Profit
$-135.0M
Gross Margin
33.3%
Operating Margin
14.8%
-43.3%
Net Margin
-82.0%
Revenue YoY
15.1%
-22.7%
Net Profit YoY
-104.8%
EPS (diluted)
$0.82
$-1.63

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ATRO
ATRO
PTCT
PTCT
Q4 25
$240.1M
$164.7M
Q3 25
$211.4M
$211.0M
Q2 25
$204.7M
$178.9M
Q1 25
$205.9M
$1.2B
Q4 24
$208.5M
$213.2M
Q3 24
$203.7M
$196.8M
Q2 24
$198.1M
$186.7M
Q1 24
$185.1M
$210.1M
Net Profit
ATRO
ATRO
PTCT
PTCT
Q4 25
$-135.0M
Q3 25
$-11.1M
$15.9M
Q2 25
$1.3M
$-64.8M
Q1 25
$9.5M
$866.6M
Q4 24
$-65.9M
Q3 24
$-11.7M
$-106.7M
Q2 24
$1.5M
$-99.2M
Q1 24
$-3.2M
$-91.6M
Gross Margin
ATRO
ATRO
PTCT
PTCT
Q4 25
33.3%
Q3 25
30.5%
Q2 25
25.8%
Q1 25
29.5%
Q4 24
29.8%
Q3 24
27.1%
Q2 24
28.0%
Q1 24
25.7%
Operating Margin
ATRO
ATRO
PTCT
PTCT
Q4 25
14.8%
-43.3%
Q3 25
10.9%
1.4%
Q2 25
2.3%
-19.5%
Q1 25
6.4%
82.5%
Q4 24
4.3%
-76.2%
Q3 24
4.1%
-27.7%
Q2 24
3.8%
-21.5%
Q1 24
0.9%
-21.6%
Net Margin
ATRO
ATRO
PTCT
PTCT
Q4 25
-82.0%
Q3 25
-5.2%
7.5%
Q2 25
0.6%
-36.3%
Q1 25
4.6%
73.7%
Q4 24
-30.9%
Q3 24
-5.8%
-54.2%
Q2 24
0.8%
-53.1%
Q1 24
-1.7%
-43.6%
EPS (diluted)
ATRO
ATRO
PTCT
PTCT
Q4 25
$0.82
$-1.63
Q3 25
$-0.31
$0.20
Q2 25
$0.04
$-0.83
Q1 25
$0.26
$10.04
Q4 24
$-0.07
$-0.85
Q3 24
$-0.34
$-1.39
Q2 24
$0.04
$-1.29
Q1 24
$-0.09
$-1.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ATRO
ATRO
PTCT
PTCT
Cash + ST InvestmentsLiquidity on hand
$18.2M
$1.9B
Total DebtLower is stronger
Stockholders' EquityBook value
$140.1M
$-205.3M
Total Assets
$706.7M
$2.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ATRO
ATRO
PTCT
PTCT
Q4 25
$18.2M
$1.9B
Q3 25
$13.5M
$1.7B
Q2 25
$13.5M
$2.0B
Q1 25
$24.8M
$2.0B
Q4 24
$9.3M
$1.1B
Q3 24
$5.2M
$1.0B
Q2 24
$2.9M
$1.1B
Q1 24
$5.3M
$884.8M
Stockholders' Equity
ATRO
ATRO
PTCT
PTCT
Q4 25
$140.1M
$-205.3M
Q3 25
$108.9M
$-155.8M
Q2 25
$271.6M
$-206.5M
Q1 25
$266.8M
$-185.8M
Q4 24
$256.1M
$-1.1B
Q3 24
$249.2M
$-1.1B
Q2 24
$257.9M
$-980.2M
Q1 24
$251.7M
$-893.9M
Total Assets
ATRO
ATRO
PTCT
PTCT
Q4 25
$706.7M
$2.9B
Q3 25
$682.2M
$2.6B
Q2 25
$646.7M
$2.6B
Q1 25
$662.2M
$2.7B
Q4 24
$648.8M
$1.7B
Q3 24
$651.6M
$1.8B
Q2 24
$644.9M
$1.9B
Q1 24
$630.0M
$1.8B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ATRO
ATRO
PTCT
PTCT
Operating Cash FlowLast quarter
$27.6M
$-34.3M
Free Cash FlowOCF − Capex
$15.8M
$-36.6M
FCF MarginFCF / Revenue
6.6%
-22.3%
Capex IntensityCapex / Revenue
4.9%
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$43.1M
$702.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ATRO
ATRO
PTCT
PTCT
Q4 25
$27.6M
$-34.3M
Q3 25
$34.2M
$-66.3M
Q2 25
$-7.6M
$-58.3M
Q1 25
$20.6M
$870.1M
Q4 24
$26.4M
$-30.0M
Q3 24
$8.4M
$-77.0M
Q2 24
$-6.3M
$-71.5M
Q1 24
$2.0M
$70.8M
Free Cash Flow
ATRO
ATRO
PTCT
PTCT
Q4 25
$15.8M
$-36.6M
Q3 25
$21.0M
$-69.7M
Q2 25
$-12.2M
$-59.6M
Q1 25
$18.5M
$868.4M
Q4 24
$23.2M
$-33.8M
Q3 24
$6.5M
$-77.5M
Q2 24
$-8.1M
$-78.8M
Q1 24
$439.0K
$61.2M
FCF Margin
ATRO
ATRO
PTCT
PTCT
Q4 25
6.6%
-22.3%
Q3 25
9.9%
-33.1%
Q2 25
-6.0%
-33.3%
Q1 25
9.0%
73.8%
Q4 24
11.1%
-15.8%
Q3 24
3.2%
-39.4%
Q2 24
-4.1%
-42.2%
Q1 24
0.2%
29.1%
Capex Intensity
ATRO
ATRO
PTCT
PTCT
Q4 25
4.9%
1.4%
Q3 25
6.2%
1.6%
Q2 25
2.2%
0.7%
Q1 25
1.0%
0.1%
Q4 24
1.5%
1.8%
Q3 24
0.9%
0.3%
Q2 24
0.9%
4.0%
Q1 24
0.9%
4.6%
Cash Conversion
ATRO
ATRO
PTCT
PTCT
Q4 25
Q3 25
-4.17×
Q2 25
-5.81×
Q1 25
2.17×
1.00×
Q4 24
Q3 24
Q2 24
-4.08×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ATRO
ATRO

Product Line Electrical Power And Motion$113.8M47%
Product Line Avionics$32.0M13%
Military Aircraft$28.0M12%
General Aviation$22.3M9%
Government And Defense$20.5M9%
Product Line Systems Certification$13.2M6%
Product Line Structures$3.7M2%
Product Line Other$2.3M1%

PTCT
PTCT

Segment breakdown not available.

Related Comparisons